Delivery Order SPE2DB20D1100-SPE2DB25FB2G6

Award Date 3/19/25
Potential Completion Date 3/20/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $1,903.73 for the provision of Trulicity 0.75 mg/0.5 ml pens. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $8,145.24 and is for the delivery of Trulicity 0.75 mg/0.5 ml pens. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables efficient government...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,571.83 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,048.29 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has an ultimate completion date of September 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,749.65 and an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, with a ceiling value of $2,995.44 and a period of performance through October 26, 2023. This award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for $4,025.80. The award is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is for Trulicity 0.75 mg/0.5 ml pens and does not have a set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $1,467.12 for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a broad...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,354.82, is for the supply of Trulicity 1.5 mg/0.5 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The $2,612.52 firm fixed-price contract has an ultimate completion date of April 3, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB2G6
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $4,644.62, is for the delivery of Trulicity 0.75 mg/0.5 ml pens. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 6/18/25, 11:38 AM